Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Alexander Leads Bipartisan Support for Accelerated FDA Reviews


 

On Aug. 2, the U.S. Senate passed bipartisan legislation led by health committee Chairman Lamar Alexander (R-Tenn.) and Ranking Member Patty Murray (D-Wash.) intended to speed approval of safe drugs and medical devices.

Alexander said: "The Senate has sent to the president's desk legislation that will speed cures and treatments into patients' medicine cabinets. The first step was last year's passage of 21st Century Cures to spur medical research, and this is the next step -- ensuring patients see the benefits of those research advancements."

The legislation includes four different user fee agreements that must be reauthorized by Sept. 30. The bill is virtually identical to legislation overwhelmingly approved by the Senate's health committee on May 11. This legislation will reauthorize the authority for the Food and Drug Administration (FDA) to accept user fees - paid by manufacturers of drugs and medical devices - that account for $8 to $9 billion over 5 years and is over a quarter of all FDA funding. The reauthorizations are based on recommendations from industry and FDA after a public process.

Over the last year and a half, the HELP Committee that Alexander chairs has held 15 bipartisan briefings, including some with the House Energy and Commerce Committee, to hear from FDA and industry about the reauthorization. The HELP Committee held two bipartisan hearings, on March 21 and April 4, on the medical device and drug user fees. The committee held a markup on the bill on May 11, when two bipartisan amendments were adopted, and the committee overwhelmingly approved the bill -- voting 21 to 2.

The bill includes provisions from:

  • Sens. Isakson and Bennet to improve the medical device inspection process.
  • Sens. Hassan and Young to improve communication about abuse-deterrent opioid products.
  • Sens. Enzi and Franken to encourage medical device development for children, and make sure FDA has appropriate expertise to review devices for children.
  • Sens Roberts, Donnelly, and Burr to allow more appropriate classification of accessories used with medical devices.
  • Sens Collins, Franken, McCaskill, and Cotton to improve generic drug development and help lower prescription drug costs.
  • Sens. Hatch, Bennet, Burr, and Casey to improve access to clinical trials for all patients.
  • Sens. Bennet, Rubio, Van Hollen, and Gardner to increase the development of new drugs to treat pediatric cancers and other diseases.
 
Share:

Related Articles:


Recent Articles

Nashville's First Dedicated Clinic for Rape Exams Begins Taking Clients

Website includes interactive tool to help sexual assault victims determine if the SAFE Clinic is right for them

Read More

Practicing with Precision

Precision medicine holds great promise to tailor treatment in a manner that maximizes outcomes, yet a number of barriers exist that hinder the rapidly growing discipline's integration into daily practice.

Read More

Physician Spotlight: Brandon Downs, MD

Dr. Brandon Downs of Orthopaedic Specialists offers convenient, comprehensive services to patients who rely on his expertise in minimally invasive joint replacement and sports medicine.

Read More

Vanderbilt Bone & Joint Franklin Expands Staff, Adds Pediatric Services

Vanderbilt Bone & Joint Franklin greatly expands staff and adds pediatric services.

Read More

Regenerative Medicine in Orthopaedics

Regenerative medicine means less pain, more options for orthopaedic patients.

Read More

SJRI Opens Dickson Clinic

Southern Joint Replacement Institute opens Dickson clinic.

Read More

Health:Further Keynote Speakers Offer Energy And Insight

Although the annual Health:Further conference is best known for bringing innovative start-ups and investors together, the event also attracts healthcare and business organizations that have massive scale.

Read More

Industry Leaders Announce Innovative Orthopaedic Partnership

Saint Thomas Health, BlueCross BlueShield of Tennessee and Tennessee Orthopaedic Alliance recently announced a collaborative partnership for joint replacement.

Read More

Fighting the Good Fight

Franklin company mitigating cybersecurity risks for healthcare organizations nationwide.

Read More

Fighting the Good Fight

Franklin company mitigating cybersecurity risks for healthcare organizations nationwide.

Read More

Email Print
 
 

 

 


Tags:
FDA, HELP Committee, Lamar Alexander, U.S. Senate
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: